Dr. Brian Druker, M.D.
Claim this profileOHSU Knight Cancer Institute
Studies Anemia
Studies Leukopenia
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Brian Druker, M.D. is currently running
More about Brian Druker, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Brian Druker, M.D. has experience with
- Enasidenib
- Ivosidenib
Breakdown of trials Brian Druker, M.D. has run
Thrombocytopenia
Low blood cell count
Clonal Cytopenia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Druker, M.D. specialize in?
Brian Druker, M.D. focuses on Anemia and Leukopenia. In particular, much of their work with Anemia has involved IDH positive patients, or patients who are undergoing treatment.
Is Brian Druker, M.D. currently recruiting for clinical trials?
Yes, Brian Druker, M.D. is currently recruiting for 1 clinical trial in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Brian Druker, M.D. has studied deeply?
Yes, Brian Druker, M.D. has studied treatments such as Enasidenib, Ivosidenib.
What is the best way to schedule an appointment with Brian Druker, M.D.?
Apply for one of the trials that Brian Druker, M.D. is conducting.
What is the office address of Brian Druker, M.D.?
The office of Brian Druker, M.D. is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.